
Resident-run cardiothoracic outcomes research group @DukeSurgery
Durham, NC
Joined January 2020
- Tweets58
- Following118
- Followers529
- Likes93
Duke CT Surgery Outcomes Group retweeted
Excited for #ISHLT2021 this weekend!
Tune in on Wed April 28th from 11:45-11:50 EDT to hear our #MiniOral discussing use of 🫁 allografts w/ “extreme” ischemic times for txp
@DukeCTOutcomes @DukeSurgery @DukeCTSurgery @mghartwigmd @SJKesseli @DanaeOlaso @brandi_bottiger
Duke CT Surgery Outcomes Group retweeted
Thank you to
@STS_CTsurgery for highlighting our study in this #STS2021 press briefing:
🔹Sex Disparities on Coronary Artery Bypass Grafting Techniques
@DukeSurgery @DukeCTSurgery @DCRINews @DukeSurgRes @DukeCTOutcomes
youtube.com/watch?v=avf4RLS3…
Duke CT Surgery Outcomes Group retweeted
Just published in @SurgJournal: our @STS_CTsurgery analysis of Ravitch vs Nuss repair of pectus excavatum
🔹No difference peri-op complications after adjustment
🔹Generally a low vol procedure for CT surgeons
@DukeCTSurgery @DukeSurgery @DCRINews
surgjournal.com/article/S003…
Duke CT Surgery Outcomes Group retweeted
Our post-hoc analysis of LEVO-CTS now published in @AmericanHeartJ
🔹No association between levosimendan and post-op AKI in low EF patients undergoing cardiac surgery
@DCRINews @DukeSurgery @DukeCTSurgery @RenatoDLopes1 @DukeCTOutcomes @vigneshr11
Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial. pubmed.ncbi.nlm.nih.gov/3312…
Duke CT Surgery Outcomes Group retweeted
Just published @Transpl_Int: Center volume and primary graft dysfunction after lung transplant
🔹Near linear association b/w ⬆️ center volume and ⬇️ likelihood of grade 3 PGD
🔹Improved survival after PGD with ⬆️ volume at low and medium volume centers
onlinelibrary.wiley.com/doi/…
Duke CT Surgery Outcomes Group retweeted
Just published in @AATSJournals #JTCVS: Factors associated with short- versus long-term survival after lung transplant
🔹Minimal overlap between factors associated with 1- and 10-year survival
🔹Widely used LAS not associated with long-term survival
sciencedirect.com/science/ar…
Duke CT Surgery Outcomes Group retweeted
Just published @AmericanHeartJ: Post-hoc analysis of LEVO-CTS trial examining association between levosimendan and AKI in low EF cardiac surgery patients
🔹Levosimendan NOT associated with risk of AKI
@DCRINews @DukeSurgery @DukeCTSurgery @DukeHeartCenter @Duke_Anesthesia
In Press: Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial. sciencedirect.com/science/ar…
Duke CT Surgery Outcomes Group retweeted
Amazing work by @sehalpern5 and team!
Paradigm-shifting work introducing a new way to evaluate the performance of OPOs - an integral aspect of the US transplant system #TransplantTwitter
@DukeSurgery @DukeCTSurgery @DukeCTOutcomes @CRTP_DukeSOM @amjtransplant @tssmn
🔥Hot off the press🔥 We proposed a new 3-tier system for OPO performance evaluation in #LungTxp out now in @amjtransplant. Huge thanks & congrats to the whole team! @ojawitzMD @vigneshr11 @AshleyYJChoi @mghartwigmd @CMSGov @UNOSNews
onlinelibrary.wiley.com/doi/…
Duke CT Surgery Outcomes Group retweeted
🔥Hot off the press🔥 We proposed a new 3-tier system for OPO performance evaluation in #LungTxp out now in @amjtransplant. Huge thanks & congrats to the whole team! @ojawitzMD @vigneshr11 @AshleyYJChoi @mghartwigmd @CMSGov @UNOSNews
onlinelibrary.wiley.com/doi/…
Duke CT Surgery Outcomes Group retweeted
Outstanding editorial comment by @ojawitzMD from @DukeSurgery @DukeCTSurgery @DCRINews on our Explant TAVR paper.
👇👇
onlinejacc.org/content/76/16…
🔥🔥Timely study on TAVR Explants from @BWHSurgery @TsuyoshiKaneko1 #TAVR @TSRA_official @PinakShahMD @BrighamResearch @DLBHATTMD
"Although the overall incidence remains ⬇️, short-term mortality is ⬆️" - Important implications as TAVR expands to low-risk and young patients.
HIV+ heart transplant recipients fared no worse than HIV- counterparts in 30-d, 5-yr survival. HIV+ should not, in isolation, be an absolute contraindication to OHT. Pub here: pubmed.ncbi.nlm.nih.gov/3294…
@JacobNiall @DukeHeartCenter @DukeCTSurgery @benbryner @ojawitzMD @vigneshr11
Duke CT Surgery Outcomes Group retweeted
Online now @amjtransplant! Our lung transplant experience during the early #COVID19 pandemic. onlinelibrary.wiley.com/doi/…
✅pre-txp testing
✅risk factor screening
✅local procurements
⬆️txp volume
@mghartwigmd @DanaeOlaso @DukeSurgery @DukeCTSurgery
Duke CT Surgery Outcomes Group retweeted
Now in press at Perfusion, we describe an operation strategy (STAR perfusion) that could decrease ischemic time during complex Norwood procedures by over 2 fold. Excited to see this out, thanks to the guidance of @TurekPedHearts! @DukeCTOutcomes doi.org/10.1177/026765912095…
Duke CT Surgery Outcomes Group retweeted
Excited to see our NCDB analysis on the impact of age of surgical outcomes for locally advanced esophageal cancer available online @annalsthorsurg annalsthoracicsurgery.org/ar… Thanks to @vigneshr11 @ojawitzMD @BTongMD and Drs D'Amico & Harpole for their work on this.
Congratulations to @AJustinRucker2, @krisrho93, and @soraya_voigtMD on their abstracts accepted to @AATSHQ #ITSOS2020!
@krisrho93 will present a poster on disparities in guideline-concordant adjuvant chemo in node-positive esophageal cancer. @soraya_voigtMD's poster examines tumor size and adjuvant chemo in node-negative esophageal cancer.
1
3
Thanks: @BTongMD @ojawitzMD @vigneshr11 @DukeSurgRes @DukeCTSurgery @ECUSurgery and Drs. Harpole and D'Amico
3
Duke CT Surgery Outcomes Group retweeted
Check out our contribution in the new special #ERASCardiac issue of @CritCareClinics:
🔹How to start an #ERAS Cardiac program
@JudsonBWilliams @danengelmanmd @DukeCTSurgery @DukeHeartCenter @DukeSurgery @DCRINews @WakeMed
criticalcare.theclinics.com/…
Duke CT Surgery Outcomes Group retweeted
Hot off the press! @mghartwigmd and I comment on use of “distant” donor lungs under the new #LungAllocationPolicy in @AATSJournals. For now we go the distance, but perhaps we don’t have to. doi.org/10.1016/j.jtcvs.2020…
@DukeCTSurgery @DukeCTOutcomes


















